PMS expiration of Twynsta on August next year

‘Twynsta(telmisasrtan-amlodipine),’ the top sales hypertension treatment, has active competition ahead for the same substance drug due to expiration of post-marketing surveillance(PMS) on August next year.

A number of domestic pharmaceutical companies are getting ready for the competition by third complex drugs combined with generics, Twynsta diuretics or hyperlipidemia treatments. The interes...